Delfi Diagnostics Announces $225 Million Series B Financing To Develop Globally Accessible Portfolio Of Liquid Biopsy Tests
Amount Raised
$225 Million
Round Type
Series B
BaltimoreBiotechnologyDescription
Delfi Diagnostics, Inc., a pioneering developer of a new class of high-performance, accessible liquid biopsy tests for early cancer detection and monitoring, today announced a Series B funding of $225 million.
Quick answer
DELFI Diagnostics raised $225 Million in a Series B round, dated July 18, 2022. DELFI Diagnostics is based in Baltimore, Maryland, United States.
- How much did DELFI Diagnostics raise?
- DELFI Diagnostics raised $225 Million in a Series B round on July 18, 2022.
- What does DELFI Diagnostics do?
- DELFI Diagnostics is developing next-generation blood-based cancer detection tests designed to be accurate, accessible, and scalable for population health.
- Where is DELFI Diagnostics based and how big is it?
- DELFI Diagnostics is based in Baltimore, Maryland, United States. Fundz records about 171 employees.
- Who are the decision-makers at DELFI Diagnostics?
- Fundz holds 3 contacts at DELFI Diagnostics, including the Vice President Quality Regulatory & Lab Operations. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as DELFI Diagnostics that raised within 45 days of this round, from Fundz verified event records.
- Ceres Nanosciences, Inc. raised $5M on September 1, 2022.
- Neurolens raised $68M on September 1, 2022.
- Puna Bio raised $3.7M (Seed) on September 1, 2022.
- FathomX raised an undisclosed amount (Pre-Series A) on September 1, 2022.
- Bekaert raised an undisclosed amount on September 1, 2022.
- Ostial Corporation raised $7.7M on September 1, 2022.
Who to call at DELFI Diagnostics, and when
A new round usually means DELFI Diagnostics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day DELFI Diagnostics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at DELFI Diagnostics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at DELFI Diagnostics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment DELFI Diagnostics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansDELFI Diagnostics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.